Gene therapy using IL-27 ameliorates Sjogren's syndrome-like autoimmune exocrinopathy

被引:40
作者
Lee, Byung Ha [1 ,2 ]
Carcamo, Wendy C. [2 ]
Chiorini, John A. [3 ]
Peck, Ammon B. [2 ,4 ,5 ]
Nguyen, Cuong Q. [4 ,6 ]
机构
[1] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA
[3] Natl Inst Dent & Cranial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA
[4] Univ Florida, Coll Dent, Ctr Orphan Autoimmune Disorders, Gainesville, FL 32610 USA
[5] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
[6] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32608 USA
关键词
ADENOASSOCIATED VIRUS VECTOR; SYNDROME-LIKE DISEASE; REGULATORY T-CELLS; CYSTIC-FIBROSIS; SALIVARY-GLANDS; AUTOANTIBODY PRODUCTION; LYMPHOCYTE POPULATIONS; TRANSGENE EXPRESSION; CYTOKINE PRODUCTION; ADENOVIRUS VECTORS;
D O I
10.1186/ar3925
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Sjogren's syndrome (SjS) is a systemic autoimmune disease characterized by decreased salivary and lacrimal gland secretions, resulting in severe dry mouth and dry eyes. Recent studies have suggested that T(H)17 cells and its signature cytokine IL-17 are involved in the underlying pathogenic mechanisms leading to destructive inflammation and autoimmunity. In the present study, we examined whether IL-27, a natural inhibitor of T(H)17 activity, could down-regulate or reverse SjS in C57BL/6.NOD-Aec1Aec2 mice, a model of primary-SjS. Methods: Recombinant serotype 2 adeno-associated viral (AAV2) vectors expressing either IL-27 (rAAV2-IL27) or LacZ (rAAV2-LacZ) were injected into 6 or 14 week-old C57BL/6.NOD-Aec1Aec2 mice. Changes in IL-27, IL-17, and IL-10 cytokine levels in peripheral blood were determined by ELISAs, while flow cytometry analyses were used to quantify cytokine-positive splenocytes. Histological assessment of salivary glands, anti-nuclear autoantibody (ANA) staining, and stimulated saliva flow rates were used to profile SjS disease severity. Results: Mice systemically treated with intravenous rAAV2-IL27 injections at either 6 or 14 weeks of age exhibited long-term elevated levels of serum IL-27 with concomitantly reduced levels of IL-17 compared with sera from mice injected with rAAV2-LacZ or saline out to 20 weeks post-inoculation. Most importantly, disease profiles revealed that rAAV2-IL27 treatment had little effect on lymphocytic focus (LF) scores, but resulted in structural changes in LF, lower titers of ANAs with changes in staining patterns, and a less severe clinical disease as determined by saliva flow rates. Conclusions: These data support the concept that IL-27, when provided exogenously, can induce a suppressive effect on SjS development and thus may be an effective therapeutic agent for regulating T(H)17 pro-inflammatory activity in autoimmune diseases where the T(H)17 system has been shown to play an important role in their pathogenesis.
引用
收藏
页数:14
相关论文
共 63 条
[1]   Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands [J].
Adesanya, MR ;
Redman, RS ;
Baum, BJ ;
OConnell, BC .
HUMAN GENE THERAPY, 1996, 7 (09) :1085-1093
[2]   Primary non-Hodgkin's lymphoma of the salivary gland: A spectrum of lymphoepithelial sialadenitis, low-grade B-cell lymphoma of mucosa-associated lymphoid tissue with transformation to high-grade lymphoma [J].
Agale, Shubhangi Vinayak ;
D'Costa, Grace Francis ;
Hastak, Meenal Shirish ;
Shedge, Rakesh Tukaram .
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2010, 53 (02) :364-367
[3]   A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells [J].
Awasthi, Amit ;
Carrier, Yijun ;
Peron, Jean P. S. ;
Bettelli, Estelle ;
Kamanaka, Masahito ;
Flavell, Richard A. ;
Kuchroo, Vijay K. ;
Oukka, Mohamed ;
Weiner, Howard L. .
NATURE IMMUNOLOGY, 2007, 8 (12) :1380-1389
[4]   The biology and therapeutic potential of interleukin 27 [J].
Batten, Marcel ;
Ghilardi, Nico .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2007, 85 (07) :661-672
[5]   Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells [J].
Batten, Marcel ;
Li, Ji ;
Yi, Sothy ;
Kljavin, Noelyn M. ;
Danilenko, Dimitry M. ;
Lucas, Sophie ;
Lee, James ;
de Sauvage, Frederic J. ;
Ghilardi, Nico .
NATURE IMMUNOLOGY, 2006, 7 (09) :929-936
[6]   Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate [J].
Bombardieri, M ;
Barone, F ;
Pittoni, V ;
Alessandri, C ;
Conigliaro, P ;
Blades, MC ;
Priori, R ;
McInnes, IB ;
Valesini, G ;
Pitzalis, C .
ARTHRITIS RESEARCH & THERAPY, 2004, 6 (05) :R447-R456
[7]   Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration [J].
Bostick, B. ;
Ghosh, A. ;
Yue, Y. ;
Long, C. ;
Duan, D. .
GENE THERAPY, 2007, 14 (22) :1605-1609
[8]   Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjogren's syndrome) on a healthy murine background [J].
Cha, S ;
Nagashima, H ;
Brown, VB ;
Peck, AB ;
Humphreys-Beher, MG .
ARTHRITIS AND RHEUMATISM, 2002, 46 (05) :1390-1398
[9]   Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors [J].
Chu, D ;
Sullivan, CC ;
Weitzman, MD ;
Du, L ;
Wolf, PL ;
Jamieson, SW ;
Thistlethwaite, PA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (03) :671-679
[10]  
Conrad CK, 1996, GENE THER, V3, P658